KIF2C and triple-negative breast carcinoma: In support of this idea, MCAK inhibition has been shown to induce aneuploidy and reduce the viability of genomically unstable cancers like triple-negative breast cancer [181], warranting additional research to develop MCAK-targeted drugs.